PWPCM
BIIB icon

Perella Weinberg Partners Capital Management’s Biogen BIIB Stock Holding History

Perella Weinberg Partners Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-1,740
Closed -$375K – 126
2013
Q2 		$375K Buy
+1,740
New +$372K 0.03% 211

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Perella Weinberg Partners Capital Management's BIIB Position: Q3 2013 in Review

Perella Weinberg Partners Capital Management sold out of Biogen (BIIB) in Q3 2013, closing a stake of 1,740 shares — an estimated $375K sold.

Perella Weinberg Partners Capital Management first reported a position in BIIB in Q2 2013 and held it in 1 quarter. The position peaked at $375K in Q2 2013. 656 funds tracked by Wall St. Rank hold BIIB as of Q3 2013.

  • Perella Weinberg Partners Capital Management reported no remaining Biogen position as of Q3 2013 after selling out during the quarter.
  • Perella Weinberg Partners Capital Management sold 1,740 Biogen shares in Q3 2013, an estimated $375K.
  • Perella Weinberg Partners Capital Management first reported a position in Biogen in Q2 2013 and held it in 1 quarter.
  • Perella Weinberg Partners Capital Management's Biogen position peaked at $375K in Q2 2013.
  • 656 funds tracked by Wall St. Rank held Biogen as of Q3 2013.

Based on Perella Weinberg Partners Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.